Results 151 to 160 of about 139,953 (213)

Empagliflozin enhances metabolic efficiency and improves left ventricular hypertrophy in a hypertrophic cardiomyopathy mouse model. [PDF]

Eur Heart J
Baka T, Moore J, Qin F, Yurista SR, Zhang A, He H, Chambers JM, Croteau D, Goel RK, Smith H, Wang MC, Chen CS, Hobai IA, Rombaldova M, Kuda O, Tardiff JC, Balschi JA, Pimentel DR, Seidman CE, Seidman JG, Emili A, Colucci WS, Luptak I.   +22 more
europepmc   +1 more source

Development of a smartphone-based app to support the differential diagnosis in patients with primary left ventricular hypertrophy. [PDF]

Eur Heart J Digit Health
Maurizi N, Monda E, Pieroni M, Biagini E, Field E, Passantino S, Dallaglio G, Fumagalli C, Antiochos P, Skalidis I, Lu H, Kachrimanidis I, Argirò A, Girolami F, Cecchi F, Cappelli F, Elliott PM, Kaski JP, Limongelli G, Olivotto I.   +19 more
europepmc   +1 more source

Specific associations of serum FGF23 and soluble Klotho with different types of left ventricular hypertrophy in hypertensive peritoneal dialysis patients: a cross-sectional study. [PDF]

Front Cardiovasc Med
Zhu Y, Yin X, Zhang H, Han Z, Lu J, Lin M, Chen G, Chen Y.   +7 more
europepmc   +1 more source

Myocardial Bridging With Left Ventricular Hypertrophy: A Case of Exercise-Induced Cardiac Arrest With Coronary Spasm. [PDF]

JACC Case Rep
Toya T, Naito K, Urushima T, Goda M, Takatoo M, Shimura S, Nagatomo Y, Ozaki S, Adachi T.   +8 more
europepmc   +1 more source

Association between Neutrophil-to-Lymphocyte ratio and left ventricular hypertrophy in chronic kidney disease patients: a cross-sectional study. [PDF]

BMC Cardiovasc Disord
Wang L, Zhang W, Ji J, Xiang F, Zhang L, Jiang X, Fang Y, Ding X, Jiang W.   +8 more
europepmc   +1 more source

Impact of Height Exponents: A New Diagnostic Lens for Left Ventricular Hypertrophy? [PDF]

JACC Asia
Lian X, Lu M.
europepmc   +1 more source

Association of CVAI, age, and clinic systolic blood pressure with left ventricular hypertrophy in postmenopausal women with primary hypertension: A single-centre retrospective case-control study. [PDF]

Sci Prog
Hu X, Arthur Vithran DT, Zhang Q, Malasadi N, Abudula A, Li H.   +5 more
europepmc   +1 more source

Deletion of cardiac fibroblast growth factor-23 beneficially impacts myocardial energy metabolism in left ventricular hypertrophy. [PDF]

NPJ Metab Health Dis
Latic N, Lari A, Sun N, Zupcic A, Oubounyt M, Falivene J, Buck A, Hofer M, Chang W, Kuebler WM, Baumbach J, Walch AK, Grabner A, Erben RG.   +13 more
europepmc   +1 more source

Utilization rates and determinants of PYP and CMR among patients with unexplained left ventricular hypertrophy on echocardiography. [PDF]

Int J Cardiol
Fessehaie NA, Bediako H, Kallan MJ, Levin M, Adusumalli S, Bravo P, Pieretti J, Scherrer-Crosbie M, Ferrari VA, Denduluri S, Anyanwu E, Julien H, Eberly LA.   +12 more
europepmc   +1 more source